WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joana GoncalvesChief Medical Officer2026-02-173,500$6.84
$23.94kBuy
Joana GoncalvesChief Medical Officer2026-02-17936$32.78
$30.69kSell
Joana GoncalvesChief Medical Officer2026-02-176,064$32.30
$195.87kSell
Joana GoncalvesChief Medical Officer2026-02-173,500$7.80
$27.30kBuy
Joana GoncalvesChief Medical Officer2026-01-153,500$6.84
$23.94kBuy
Joana GoncalvesChief Medical Officer2026-01-152,619$32.24
$84.43kSell
Joana GoncalvesChief Medical Officer2026-01-154,381$31.56
$138.28kSell
Joana GoncalvesChief Medical Officer2026-01-153,500$7.80
$27.30kBuy
Laura Lee SandlerChief Operating Officer2026-01-021,108$29.75
$32.97kSell
Laura Lee SandlerChief Operating Officer2026-01-025,000$7.80
$39.00kBuy

1 of 2

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Krishna Kittu Kolluri21.11%10,221,465$329.23MInsider
Harry R. Weller21.11%10,221,465$329.23MInsider
Joshua Makower21.11%10,221,465$329.23MInsider
David M. Mott21.11%10,221,465$329.23MInsider
Ravi Viswanathan21.11%10,221,465$329.23MInsider
Peter J. Barris21.11%10,221,465$329.23MInsider
Peter W. Sonsini21.11%10,221,465$329.23MInsider
Forest Baskett21.11%10,221,465$329.23MInsider
Scott D. Sandell21.11%10,221,465$329.23MInsider
Anthony A. Florence Jr.21.11%10,221,465$329.23MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA10.82%89.18%Net BuyingNet Selling
RLAY33.40%27.49%Net SellingNet Selling
RAPT21.96%78.04%
OCS27.05%0.00%
NRIX57.76%8.27%Net SellingNet Buying
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 38.56% institutional shareholders, 317.93% Oruka Therapeutics insiders, and 0.00% retail investors. Krishna Kittu Kolluri is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 21.11% of the company. Krishna Kittu Kolluri's Oruka Therapeutics shares are currently valued at $334.04M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.